We are excited to share that Altaris completed its acquisition of Advanced Therapies U.S. and OXGENE (together “Advanced Therapies”) on 7 March 2025. Advanced Therapies is now fully owned by Altaris and headquartered in the United States. As we continue to expand, we remain committed to developing life-changing therapies and building a world-class team. If you’re interested in career opportunities with us, please complete the form on this page to receive a link to our current job listings.